Treatment of infantile hemangiomas with low-dose propranolol: evaluation of short-term efficacy and safety

National Medical Journal of China

Volumn 89, Issue 44, 2009, Pages 3130-3134

  Qin, Zhong Ping ^a   Liu, Xue Jian ^a   Li, Ke Lei ^a   Zhou, Qin ^a   Yang, Xiu Juan ^a   Zheng, Jia Wei ^a  

^a Tumor Hospital of Linyi   (China)

Author keywords

Hemangioma; Infant; Propranolol

Indexed keywords

PROPRANOLOL;

ARTICLE; DOSE RESPONSE; FEMALE; HEMANGIOMA; HUMAN; INFANT; MALE; PROSPECTIVE STUDY; TREATMENT OUTCOME;

DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEMANGIOMA; HUMANS; INFANT; MALE; PROPRANOLOL; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84871521595     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0376-2491.2009.44.009     Document Type: Article

References (15)

1. Metry D. Update on hemangiomas of infancy. Curr Opin Pediatr, 2004, 16:373-377.
2. Bennett ML, Fleischer Jr AB, Chamlin SL, et al. Oral corticosteroid use is effective for cutaneous hemangiomas; an evidence-based evaluation. Arch Dermatol, 2001, 137:1208-1213.
3. Ezekowitz RAB, Mulliken JB, Folkman J. Interferon alpha 2a therapy for life threatening hemangiomas of infancy. N Engl J Med, 1992, 326:1456-1463.
4. Enjolras 0, Brevière GM, Roger G, et al. Vincristine treatment for function-and life-threatening infantile hemangioma. Arch Pediatr, 2004, 11:99-107.
5. Léauté-Labr̀ze C, Dumas de la Roque E, Hubiche T, et al. Propranolol for severe hemangiomas of infancy. N Engl J Med, 2008, 358: 2649-2651.
6. Waner M, Suen JY. A classification of congenital vascular lesions// Waner M, Suen JY. Hemangiomas and vascular malformations of the head and neck. New York; Wiley-Liss, 1999: 1-12.
7. Achauer BM, Chang CJ, Vander Kam VM. Management of hemangioma of infancy: review of 245 patients. Plast Reconstr Surg, 1997, 99:1301-1308.
8. Siegfried EC, Keenan WJ, Al-Jureidini S. More on propranolol for hemangiomas of infancy. N Engl J Med, 2008 , 359:2846.
9. Buckmiller L, Dyamenahalli U, Richter GT. Propranolol for airway hemangiomas: Case report of novel treatment. Laryngoscope, 2009, 119:2051-2054.
10. Gottschling S, Schneider G, Meyer S, et al. Two infants with life-threatening diffuse neonatal hemangiomatosis treated with cyclophosphamide. Pediatr Blood Cancer, 2006, 46:239-224.
11. Frieden IJ, Haggstrom AN, Drolet BA, et al. Infantile hemangiomas: current knowledge, future directions. Proceedings of a research workshop on infantile hemangiomas, April 7-9, 2005 , Bethesda, Maryland, USA. Pediatr Dermatol, 2005 , 22: 383406.
12. Razon MJ, Kraling BM, Mulliken JB, et al. Increased apoptosis coincides with onset of involution in infantile hemangioma. Microcirculation, 1998, 5:189-195.
13. Zhang L, Lin X, Wang W, et al. Circulating level of vascular endothelial growth factor in differentiating hemangioma from vascular malformation patients. Plast Reconstr Surg, 2005, 116: 200-204.
14. D'Angelo G, Lee H, Weiner RI. cAMP-dependent protein kinase inhibits the mitogenic action of vascular endothelial growth factor and fibroblast growth factor in capillary endothelial cells by blocking Raf activation. J Cell Biochem, 1997, 67: 353-366.
15. Sommers Smith SK, Smith DM. Beta blockade induces apoptosis in cultured capillary endothelial cells. In Vitro Cell Dev Biol Anim, 2002, 38:298-304.